Cyclin-Dependent Kinase 5 (CDK5) Peptide
-
- Target See all CDK5 products
- CDK5 (Cyclin-Dependent Kinase 5 (CDK5))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-CDK5 antibody (Catalog #: ARP38525_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CDK5 (Cyclin-Dependent Kinase 5 (CDK5))
- Background
-
CDK5 is probably involved in the control of the cell cycle. CDK5 can interact with d1 and d3-type G1 cyclins and phosphorylate histone H1, tau, MAP2 and NF-H and NF-M. CDK5 can also interacts with p35 which activates the kinase
Alias Symbols: PSSALRE
Protein Interaction Partner: CDK5R1,CDK5R1,ABL1,ACTN1,AMPH,APP,C1orf61,CABLES1,CABLES2,CCND2,CCNG1,CDC37,CDK16,CDK5,CDK5R1,CDK5R2,CDK5RAP1,CDKN1B,CHN1,CSNK1D,DAB1,DCX,DNM1,ERBB3,EZR,FSD1,FYN,GAK,GRIN2A,GSK3B,MAP2K1,MAPK10,MAPT,MAPT,MAPT,MEF2A,NDEL1,NES,PAK1,PCNA,PIP5K1C,PPP1R1B,PPP1R2,PSEN1,PTPN2,PURA,SET,SRC,STX1A,STXBP1,SYN1,SYNJ1,TP53,WASF1,BRCA1,CABLES2,CCND2,CDK16,CDK5R1,CDK5RAP2,GAK,LMTK2,NDEL1,NES,PAK1,PARK2,STX1A,STXBP1,TP53
Protein Size: 292 - Molecular Weight
- 33 kDa
- Gene ID
- 1020
- NCBI Accession
- NM_004935, NP_004926
- UniProt
- Q00535
-